| Year |
Citation |
Score |
| 2023 |
Rocchetti J, Fasano C, Dal-Bo G, Guma E, El Mestikawy S, Wong TP, Fakhfouri G, Giros B. Persistent extrasynaptic hyperdopaminergia in the mouse hippocampus induces plasticity and recognition memory deficits reversed by the atypical antipsychotic sulpiride. Plos One. 18: e0289770. PMID 37624765 DOI: 10.1371/journal.pone.0289770 |
0.648 |
|
| 2022 |
Cristofari P, Desplanque M, Poirel O, Hébert A, Dumas S, Herzog E, Danglot L, Geny D, Gilles JF, Geeverding A, Bolte S, Canette A, Trichet M, Fabre V, Daumas S, ... ... El Mestikawy S, et al. Nanoscopic distribution of VAChT and VGLUT3 in striatal cholinergic varicosities suggests colocalization and segregation of the two transporters in synaptic vesicles. Frontiers in Molecular Neuroscience. 15: 991732. PMID 36176961 DOI: 10.3389/fnmol.2022.991732 |
0.437 |
|
| 2022 |
Ibrahim KS, El Mestikawy S, Abd-Elrahman KS, Ferguson SSG. VGLUT3 ablation differentially modulates glutamate receptor densities in mouse brain. Eneuro. PMID 35443989 DOI: 10.1523/ENEURO.0041-22.2022 |
0.382 |
|
| 2022 |
Kljakic O, Janíčková H, Skirzewski M, Reichelt A, Memar S, El Mestikawy S, Li Y, Saksida LM, Bussey TJ, Prado VF, Prado MAM. Functional dissociation of behavioral effects from acetylcholine and glutamate released from cholinergic striatal interneurons. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 36: e22135. PMID 35032355 DOI: 10.1096/fj.202101425R |
0.33 |
|
| 2021 |
Favier M, Pietrancosta N, El Mestikawy S, Gangarossa G. Leveraging VGLUT3 Functions to Untangle Brain Dysfunctions. Trends in Pharmacological Sciences. PMID 33775453 DOI: 10.1016/j.tips.2021.03.003 |
0.352 |
|
| 2020 |
Favier M, Janickova H, Justo D, Kljakic O, Runtz L, Natsheh JY, Pascoal TA, Germann J, Gallino D, Kang JI, Meng XQ, Antinora C, Raulic S, Jacobsen JP, Moquin L, ... ... El Mestikawy S, et al. Cholinergic dysfunction in the dorsal striatum promotes habit formation and maladaptive eating. The Journal of Clinical Investigation. PMID 33164988 DOI: 10.1172/JCI138532 |
0.489 |
|
| 2020 |
Ibrahim KS, Abd-Elrahman KS, El Mestikawy S, Ferguson SSG. Targeting Vesicular Glutamate Transporter Machinery: Implications on Metabotropic Glutamate Receptor 5 Signaling and Behavior. Molecular Pharmacology. 98: 314-327. PMID 32873747 DOI: 10.1124/mol.120.000089 |
0.363 |
|
| 2020 |
Pietrancosta N, Djibo M, Daumas S, El Mestikawy S, Erickson JD. Molecular, Structural, Functional, and Pharmacological Sites for Vesicular Glutamate Transporter Regulation. Molecular Neurobiology. PMID 32474835 DOI: 10.1007/s12035-020-01912-7 |
0.433 |
|
| 2019 |
Poirel O, Mamer LE, Herman MA, Arnulf-Kempcke M, Kervern M, Potier B, Miot S, Wang J, Favre-Besse FC, Brabet I, Laras Y, Bertrand HO, Acher F, Pin JP, Puel JL, ... ... El Mestikawy S, et al. LSP5-2157 a new inhibitor of vesicular glutamate transporters. Neuropharmacology. 107902. PMID 31811873 DOI: 10.1016/J.Neuropharm.2019.107902 |
0.739 |
|
| 2019 |
Zhang XM, François U, Silm K, Angelo MF, Fernandez-Busch MV, Maged M, Martin C, Bernard V, Cordelières FP, Deshors M, Pons S, Maskos U, Bemelmans AP, Wojcik SM, El Mestikawy S, et al. A proline-rich motif on VGLUT1 reduces synaptic vesicle super-pool and spontaneous release frequency. Elife. 8. PMID 31663854 DOI: 10.7554/Elife.50401 |
0.777 |
|
| 2018 |
Trudeau LE, El Mestikawy S. Glutamate Cotransmission in Cholinergic, GABAergic and Monoamine Systems: Contrasts and Commonalities. Frontiers in Neural Circuits. 12: 113. PMID 30618649 DOI: 10.3389/Fncir.2018.00113 |
0.366 |
|
| 2018 |
Mansouri-Guilani N, Bernard V, Vigneault E, Vialou V, Daumas S, El Mestikawy S, Gangarossa G. VGLUT3 gates psychomotor effects induced by amphetamine. Journal of Neurochemistry. PMID 30556914 DOI: 10.1111/jnc.14644 |
0.354 |
|
| 2018 |
Lambert L, Dubayle D, Fafouri A, Herzog E, Csaba Z, Dournaud P, El Mestikawy S, Bernard V. Endocytosis of Activated Muscarinic m2 Receptor (m2R) in Live Mouse Hippocampal Neurons Occurs via a Clathrin-Dependent Pathway. Frontiers in Cellular Neuroscience. 12: 450. PMID 30555302 DOI: 10.3389/Fncel.2018.00450 |
0.772 |
|
| 2018 |
Poirel O, Mella S, Videau C, Ramet L, Davoli MA, Herzog E, Katsel P, Mechawar N, Haroutunian V, Epelbaum J, Daumas S, El Mestikawy S. Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer's disease at various cognitive stages. Scientific Reports. 8: 938. PMID 29343737 DOI: 10.1038/S41598-018-19154-Y |
0.807 |
|
| 2017 |
Fasano C, Rocchetti J, Pietrajtis K, Zander JF, Manseau F, Sakae DY, Marcus-Sells M, Ramet L, Morel LJ, Carrel D, Dumas S, Bolte S, Bernard V, Vigneault E, Goutagny R, ... ... El Mestikawy S, et al. Regulation of the Hippocampal Network by VGLUT3-Positive CCK- GABAergic Basket Cells. Frontiers in Cellular Neuroscience. 11: 140. PMID 28559797 DOI: 10.3389/Fncel.2017.00140 |
0.736 |
|
| 2017 |
Ramet L, Zimmermann J, Bersot T, Poirel O, De Gois S, Silm K, Yae Sakae D, Mansouri-Guilani N, Bourque MJ, Trudeau LE, Pietrancosta N, Daumas S, Bernard V, Rosenmund C, El Mestikawy S. Characterization of a human point mutation of VGLUT3 (p.A211V) in the rodent brain suggests a non-uniform distribution of the transporter in synaptic vesicles. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28314816 DOI: 10.1523/Jneurosci.0282-16.2017 |
0.805 |
|
| 2015 |
Gangarossa G, Guzman M, Prado VF, Prado MA, Daumas S, El Mestikawy S, Valjent E. Role of the atypical vesicular glutamate transporter VGLUT3 in l-DOPA-induced dyskinesia. Neurobiology of Disease. PMID 26711621 DOI: 10.1016/J.Nbd.2015.12.010 |
0.301 |
|
| 2015 |
Sakae DY, Marti F, Lecca S, Vorspan F, Martín-García E, Morel LJ, Henrion A, Gutiérrez-Cuesta J, Besnard A, Heck N, Herzog E, Bolte S, Prado VF, Prado MA, Bellivier F, ... ... El Mestikawy S, et al. The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens. Molecular Psychiatry. 20: 1448-59. PMID 26239290 DOI: 10.1038/Mp.2015.104 |
0.786 |
|
| 2015 |
Vigneault É, Poirel O, Riad M, Prud'homme J, Dumas S, Turecki G, Fasano C, Mechawar N, El Mestikawy S. Distribution of vesicular glutamate transporters in the human brain. Frontiers in Neuroanatomy. 9: 23. PMID 25798091 DOI: 10.3389/Fnana.2015.00023 |
0.389 |
|
| 2015 |
Thibault D, Giguère N, Loustalot F, Bourque MJ, Ducrot C, El Mestikawy S, Trudeau LÉ. Homeostatic regulation of excitatory synapses on striatal medium spiny neurons expressing the D2 dopamine receptor. Brain Structure & Function. PMID 25782435 DOI: 10.1007/S00429-015-1029-4 |
0.393 |
|
| 2015 |
Sakae DY, Marti F, Lecca S, Vorspan F, Martín-García E, Morel LJ, Henrion A, Gutiérrez-Cuesta J, Besnard A, Heck N, Herzog E, Bolte S, Prado VF, Prado MAM, Bellivier F, ... ... El Mestikawy S, et al. The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens Molecular Psychiatry. DOI: 10.1038/mp.2015.104 |
0.776 |
|
| 2014 |
Hepp R, Hay YA, Aguado C, Lujan R, Dauphinot L, Potier MC, Nomura S, Poirel O, El Mestikawy S, Lambolez B, Tricoire L. Glutamate receptors of the delta family are widely expressed in the adult brain. Brain Structure & Function. PMID 25001082 DOI: 10.1007/s00429-014-0827-4 |
0.355 |
|
| 2014 |
Favre-Besse FC, Poirel O, Bersot T, Kim-Grellier E, Daumas S, El Mestikawy S, Acher FC, Pietrancosta N. Design, synthesis and biological evaluation of small-azo-dyes as potent Vesicular Glutamate Transporters inhibitors. European Journal of Medicinal Chemistry. 78: 236-47. PMID 24686010 DOI: 10.1016/J.Ejmech.2014.03.056 |
0.361 |
|
| 2013 |
Favier M, Carcenac C, Drui G, Boulet S, El Mestikawy S, Savasta M. High-frequency stimulation of the subthalamic nucleus modifies the expression of vesicular glutamate transporters in basal ganglia in a rat model of Parkinson's disease. Bmc Neuroscience. 14: 152. PMID 24308494 DOI: 10.1186/1471-2202-14-152 |
0.349 |
|
| 2013 |
Siksou L, Silm K, Biesemann C, Nehring RB, Wojcik SM, Triller A, El Mestikawy S, Marty S, Herzog E. A role for vesicular glutamate transporter 1 in synaptic vesicle clustering and mobility. The European Journal of Neuroscience. 37: 1631-42. PMID 23581566 DOI: 10.1111/Ejn.12199 |
0.8 |
|
| 2012 |
Farley S, Dumas S, El Mestikawy S, Giros B. Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801. Neuropharmacology. 62: 503-17. PMID 21945287 DOI: 10.1016/J.Neuropharm.2011.09.010 |
0.626 |
|
| 2011 |
Herzog E, Nadrigny F, Silm K, Biesemann C, Helling I, Bersot T, Steffens H, Schwartzmann R, Nägerl UV, El Mestikawy S, Rhee J, Kirchhoff F, Brose N. In vivo imaging of intersynaptic vesicle exchange using VGLUT1 Venus knock-in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 15544-59. PMID 22031900 DOI: 10.1523/Jneurosci.2073-11.2011 |
0.779 |
|
| 2011 |
El Mestikawy S, Wallén-Mackenzie A, Fortin GM, Descarries L, Trudeau LE. From glutamate co-release to vesicular synergy: vesicular glutamate transporters. Nature Reviews. Neuroscience. 12: 204-16. PMID 21415847 DOI: 10.1038/Nrn2969 |
0.41 |
|
| 2010 |
Pietrancosta N, Kessler A, Favre-Besse FC, Triballeau N, Quentin T, Giros B, El Mestikawy S, Acher FC. Rose Bengal analogs and vesicular glutamate transporters (VGLUTs). Bioorganic & Medicinal Chemistry. 18: 6922-33. PMID 20708942 DOI: 10.1016/J.Bmc.2010.06.069 |
0.727 |
|
| 2010 |
Amilhon B, Lepicard E, Renoir T, Mongeau R, Popa D, Poirel O, Miot S, Gras C, Gardier AM, Gallego J, Hamon M, Lanfumey L, Gasnier B, Giros B, El Mestikawy S. VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 2198-210. PMID 20147547 DOI: 10.1523/Jneurosci.5196-09.2010 |
0.728 |
|
| 2008 |
Parra LA, Baust T, El Mestikawy S, Quiroz M, Hoffman B, Haflett JM, Yao JK, Torres GE. The orphan transporter Rxt1/NTT4 (SLC6A17) functions as a synaptic vesicle amino acid transporter selective for proline, glycine, leucine, and alanine. Molecular Pharmacology. 74: 1521-32. PMID 18768736 DOI: 10.1124/mol.108.050005 |
0.394 |
|
| 2008 |
Ruel J, Emery S, Nouvian R, Bersot T, Amilhon B, Van Rybroek JM, Rebillard G, Lenoir M, Eybalin M, Delprat B, Sivakumaran TA, Giros B, El Mestikawy S, Moser T, Smith RJ, et al. Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice. American Journal of Human Genetics. 83: 278-92. PMID 18674745 DOI: 10.1016/J.Ajhg.2008.07.008 |
0.713 |
|
| 2008 |
Gras C, Amilhon B, Lepicard EM, Poirel O, Vinatier J, Herbin M, Dumas S, Tzavara ET, Wade MR, Nomikos GG, Hanoun N, Saurini F, Kemel ML, Gasnier B, Giros B, ... El Mestikawy S, et al. The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone. Nature Neuroscience. 11: 292-300. PMID 18278042 DOI: 10.1038/Nn2052 |
0.769 |
|
| 2008 |
Moutsimilli L, Farley S, El Khoury MA, Chamot C, Sibarita JB, Racine V, El Mestikawy S, Mathieu F, Dumas S, Giros B, Tzavara ET. Antipsychotics increase vesicular glutamate transporter 2 (VGLUT2) expression in thalamolimbic pathways. Neuropharmacology. 54: 497-508. PMID 18155072 DOI: 10.1016/J.Neuropharm.2007.10.022 |
0.72 |
|
| 2008 |
Kashani A, Lepicard E, Poirel O, Videau C, David JP, Fallet-Bianco C, Simon A, Delacourte A, Giros B, Epelbaum J, Betancur C, El Mestikawy S. Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease. Neurobiology of Aging. 29: 1619-30. PMID 17531353 DOI: 10.1016/J.Neurobiolaging.2007.04.010 |
0.63 |
|
| 2007 |
Kashani A, Betancur C, Giros B, Hirsch E, El Mestikawy S. Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease. Neurobiology of Aging. 28: 568-78. PMID 16563567 DOI: 10.1016/J.Neurobiolaging.2006.02.010 |
0.673 |
|
| 2006 |
Tremolizzo L, DiFrancesco JC, Rodriguez-Menendez V, Sirtori E, Longoni M, Cassetti A, Bossi M, El Mestikawy S, Cavaletti G, Ferrarese C. Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation. Neuroscience Letters. 404: 262-5. PMID 16814469 DOI: 10.1016/j.neulet.2006.06.015 |
0.389 |
|
| 2006 |
Mannoury la Cour C, El Mestikawy S, Hanoun N, Hamon M, Lanfumey L. Regional differences in the coupling of 5-hydroxytryptamine-1A receptors to G proteins in the rat brain. Molecular Pharmacology. 70: 1013-21. PMID 16772521 DOI: 10.1124/mol.106.022756 |
0.408 |
|
| 2006 |
Vinatier J, Herzog E, Plamont MA, Wojcik SM, Schmidt A, Brose N, Daviet L, El Mestikawy S, Giros B. Interaction between the vesicular glutamate transporter type 1 and endophilin A1, a protein essential for endocytosis. Journal of Neurochemistry. 97: 1111-25. PMID 16606361 DOI: 10.1111/J.1471-4159.2006.03821.X |
0.809 |
|
| 2005 |
Gras C, Vinatier J, Amilhon B, Guerci A, Christov C, Ravassard P, Giros B, El Mestikawy S. Developmentally regulated expression of VGLUT3 during early post-natal life. Neuropharmacology. 49: 901-11. PMID 16182324 DOI: 10.1016/J.Neuropharm.2005.07.023 |
0.72 |
|
| 2005 |
Moutsimilli L, Farley S, Dumas S, El Mestikawy S, Giros B, Tzavara ET. Selective cortical VGLUT1 increase as a marker for antidepressant activity. Neuropharmacology. 49: 890-900. PMID 16111724 DOI: 10.1016/J.Neuropharm.2005.06.017 |
0.686 |
|
| 2004 |
Herzog E, Landry M, Buhler E, Bouali-Benazzouz R, Legay C, Henderson CE, Nagy F, Dreyfus P, Giros B, El Mestikawy S. Expression of vesicular glutamate transporters, VGLUT1 and VGLUT2, in cholinergic spinal motoneurons. The European Journal of Neuroscience. 20: 1752-60. PMID 15379996 DOI: 10.1111/J.1460-9568.2004.03628.X |
0.808 |
|
| 2004 |
Somogyi J, Baude A, Omori Y, Shimizu H, El Mestikawy S, Fukaya M, Shigemoto R, Watanabe M, Somogyi P. GABAergic basket cells expressing cholecystokinin contain vesicular glutamate transporter type 3 (VGLUT3) in their synaptic terminals in hippocampus and isocortex of the rat. The European Journal of Neuroscience. 19: 552-69. PMID 14984406 DOI: 10.1111/j.0953-816X.2003.03091.x |
0.383 |
|
| 2004 |
Herzog E, Gilchrist J, Gras C, Muzerelle A, Ravassard P, Giros B, Gaspar P, El Mestikawy S. Localization of VGLUT3, the vesicular glutamate transporter type 3, in the rat brain. Neuroscience. 123: 983-1002. PMID 14751290 DOI: 10.1016/J.Neuroscience.2003.10.039 |
0.808 |
|
| 2002 |
Gras C, Herzog E, Bellenchi GC, Bernard V, Ravassard P, Pohl M, Gasnier B, Giros B, El Mestikawy S. A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 5442-51. PMID 12097496 |
0.769 |
|
| 2001 |
Herzog E, Bellenchi GC, Gras C, Bernard V, Ravassard P, Bedet C, Gasnier B, Giros B, El Mestikawy S. The existence of a second vesicular glutamate transporter specifies subpopulations of glutamatergic neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: RC181. PMID 11698619 |
0.776 |
|
| 2001 |
Sagné C, Agulhon C, Ravassard P, Darmon M, Hamon M, El Mestikawy S, Gasnier B, Giros B. Identification and characterization of a lysosomal transporter for small neutral amino acids. Proceedings of the National Academy of Sciences of the United States of America. 98: 7206-11. PMID 11390972 DOI: 10.1073/Pnas.121183498 |
0.724 |
|
| 2000 |
Masson J, Gaspar P, Aïdouni Z, Ezan P, Giros B, Hamon M, El Mestikawy S. Ontogeny of Rxt1, a vesicular "orphan" Na(+)/Cl(-)-dependent transporter, in the rat. Neuroscience. 96: 627-37. PMID 10717444 DOI: 10.1016/S0306-4522(99)00570-9 |
0.699 |
|
| 2000 |
Riad M, Garcia S, Watkins KC, Jodoin N, Doucet E, Langlois X, el Mestikawy S, Hamon M, Descarries L. Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. The Journal of Comparative Neurology. 417: 181-94. PMID 10660896 DOI: 10.1002/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A |
0.482 |
|
| 1999 |
Masson J, Sagné C, Hamon M, El Mestikawy S. Neurotransmitter transporters in the central nervous system. Pharmacological Reviews. 51: 439-64. PMID 10471414 |
0.306 |
|
| 1999 |
Kachidian P, Masson J, Aïdouni Z, Gaspar P, Hamon M, El Mestikawy S, Kerkerian-Le Goff L. The "orphan" Na+/Cl(-)-dependent transporter, Rxt1, is primarily localized within nerve endings of cortical origin in the rat striatum. Journal of Neurochemistry. 73: 623-32. PMID 10428058 DOI: 10.1046/J.1471-4159.1999.0730623.X |
0.449 |
|
| 1999 |
Fischer J, Bancila V, Mailly P, Masson J, Hamon M, El Mestikawy S, Conrath M. Immunocytochemical evidence of vesicular localization of the orphan transporter RXT1 in the rat spinal cord. Neuroscience. 92: 729-43. PMID 10408621 DOI: 10.1016/S0306-4522(99)00017-2 |
0.54 |
|
| 1999 |
Masson J, Riad M, Chaudhry F, Darmon M, Aïdouni Z, Conrath M, Giros B, Hamon M, Storm-Mathisen J, Descarries L, El Mestikawy S. Unexpected localization of the Na+/Cl--dependent-like orphan transporter, Rxt1, on synaptic vesicles in the rat central nervous system. The European Journal of Neuroscience. 11: 1349-61. PMID 10103130 DOI: 10.1046/J.1460-9568.1999.00540.X |
0.77 |
|
| 1998 |
Riad M, Tong XK, el Mestikawy S, Hamon M, Hamel E, Descarries L. Endothelial expression of the 5-hydroxytryptamine1B antimigraine drug receptor in rat and human brain microvessels. Neuroscience. 86: 1031-5. PMID 9697110 DOI: 10.1016/S0306-4522(98)00196-1 |
0.434 |
|
| 1997 |
el Mestikawy S, Wehrlé R, Masson J, Lombard MC, Hamon M, Sotelo C. Distribution pattern and ultrastructural localization of Rxt1, an orphan Na+/Cl(-)-dependent transporter, in the central nervous system of rats and mice. Neuroscience. 77: 319-33. PMID 9472393 DOI: 10.1016/S0306-4522(96)00466-6 |
0.511 |
|
| 1997 |
Sagné C, El Mestikawy S, Isambert MF, Hamon M, Henry JP, Giros B, Gasnier B. Cloning of a functional vesicular GABA and glycine transporter by screening of genome databases. Febs Letters. 417: 177-83. PMID 9395291 DOI: 10.1016/S0014-5793(97)01279-9 |
0.744 |
|
| 1997 |
Gérard C, Martres MP, Lefèvre K, Miquel MC, Vergé D, Lanfumey L, Doucet E, Hamon M, el Mestikawy S. Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system. Brain Research. 746: 207-19. PMID 9037500 DOI: 10.1016/S0006-8993(96)01224-3 |
0.425 |
|
| 1996 |
Masson J, Pohl M, Aïdouni Z, Giros B, Hamon M, el Mestikawy S. The two orphan Na+/Cl(-)-dependent transporters Rxt1 and V-7-3-2 have an overlapping expression pattern in the rat central nervous system. Receptors & Channels. 4: 227-42. PMID 9065971 |
0.682 |
|
| 1996 |
Langlois X, el Mestikawy S, Arpin M, Triller A, Hamon M, Darmon M. Differential addressing of 5-HT1A and 5-HT1B receptors in transfected LLC-PK1 epithelial cells: a model of receptor targeting in neurons. Neuroscience. 74: 297-302. PMID 8865182 DOI: 10.1016/0306-4522(96)00234-5 |
0.419 |
|
| 1996 |
Kia HK, Miquel MC, Brisorgueil MJ, Daval G, Riad M, El Mestikawy S, Hamon M, Vergé D. Immunocytochemical localization of serotonin1A receptors in the rat central nervous system. The Journal of Comparative Neurology. 365: 289-305. PMID 8822171 DOI: 10.1002/(SICI)1096-9861(19960205)365:2<289::AID-CNE7>3.0.CO;2-1 |
0.445 |
|
| 1996 |
Gérard C, el Mestikawy S, Lebrand C, Adrien J, Ruat M, Traiffort E, Hamon M, Martres MP. Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats. Synapse (New York, N.Y.). 23: 164-73. PMID 8807744 DOI: 10.1002/(Sici)1098-2396(199607)23:3<164::Aid-Syn5>3.0.Co;2-6 |
0.427 |
|
| 1995 |
Masson J, Langlois X, Lanfumey L, Gérard C, Aïdouni Z, Giros B, Hamon M, el Mestikawy S. Immunolabeling of the Na+/Cl(-)-dependent "orphan" transporter Rxt1 in the rat central nervous system. Journal of Neuroscience Research. 42: 423-32. PMID 8583511 DOI: 10.1002/Jnr.490420317 |
0.723 |
|
| 1995 |
Miquel MC, Emerit MB, Gingrich JA, Nosjean A, Hamon M, el Mestikawy S. Developmental changes in the differential expression of two serotonin 5-HT3 receptor splice variants in the rat. Journal of Neurochemistry. 65: 475-83. PMID 7616200 DOI: 10.1046/J.1471-4159.1995.65020475.X |
0.405 |
|
| 1995 |
Langlois X, Gérard C, Darmon M, Chauveau J, Hamon M, el Mestikawy S. Immunolabeling of central serotonin 5-HT1D beta receptors in the rat, mouse, and guinea pig with a specific anti-peptide antiserum. Journal of Neurochemistry. 65: 2671-81. PMID 7595565 DOI: 10.1046/J.1471-4159.1995.65062671.X |
0.391 |
|
| 1995 |
Emerit MB, Martres MP, Miquel MC, el Mestikawy S, Hamon M. Differentiation alters the expression of the two splice variants of the serotonin 5-HT3 receptor-A mRNA in NG108-15 cells. Journal of Neurochemistry. 65: 1917-25. PMID 7595474 DOI: 10.1046/J.1471-4159.1995.65051917.X |
0.409 |
|
| 1994 |
el Mestikawy S, Giros B, Pohl M, Hamon M, Kingsmore SF, Seldin MF, Caron MG. Characterization of an atypical member of the Na+/Cl(-)-dependent transporter family: chromosomal localization and distribution in GABAergic and glutamatergic neurons in the rat brain. Journal of Neurochemistry. 62: 445-55. PMID 8294906 DOI: 10.1046/J.1471-4159.1994.62020445.X |
0.785 |
|
| 1994 |
Gérard C, Langlois X, Gingrich J, Doucet E, Vergé D, Kia HK, Raisman R, Gozlan H, el Mestikawy S, Hamon M. Production and characterization of polyclonal antibodies recognizing the intracytoplasmic third loop of the 5-hydroxytryptamine1A receptor. Neuroscience. 62: 721-39. PMID 7870302 DOI: 10.1016/0306-4522(94)90472-3 |
0.449 |
|
| 1992 |
Giros B, el Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T, Caron MG. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Molecular Pharmacology. 42: 383-90. PMID 1406597 |
0.674 |
|
| 1992 |
Giros B, El Mestikawy S, Godinot N, Yang-Feng T, Caron MG. Molecular cloning, pharmacological characterization and genetic studies of the human dopamine transporter European Neuropsychopharmacology. 2: 268-269. DOI: 10.1016/0924-977X(92)90103-F |
0.688 |
|
| 1991 |
Giros B, el Mestikawy S, Bertrand L, Caron MG. Cloning and functional characterization of a cocaine-sensitive dopamine transporter. Febs Letters. 295: 149-54. PMID 1765147 DOI: 10.1016/0014-5793(91)81406-X |
0.737 |
|
| 1991 |
Miquel MC, Doucet E, Boni C, El Mestikawy S, Matthiessen L, Daval G, Verge D, Hamon M. Central serotonin1A receptors: Respective distributions of encoding mRNA, receptor protein and binding sites by in situ hybridization histochemistry, radioimmunohistochemistry and autoradiographic mapping in the rat brain Neurochemistry International. 19: 453-465. DOI: 10.1016/0197-0186(91)90063-J |
0.454 |
|
| 1990 |
Sotelo C, Cholley B, El Mestikawy S, Gozlan H, Hamon M. Direct Immunohistochemical Evidence of the Existence of 5-HT1A Autoreceptors on Serotoninergic Neurons in the Midbrain Raphe Nuclei. The European Journal of Neuroscience. 2: 1144-1154. PMID 12106075 DOI: 10.1111/J.1460-9568.1990.Tb00026.X |
0.433 |
|
| 1990 |
Gozlan H, Daval G, Verge D, Spampinato U, Fattaccini CM, Gallissot MC, el Mestikawy S, Hamon M. Aging associated changes in serotoninergic and dopaminergic pre- and postsynaptic neurochemical markers in the rat brain. Neurobiology of Aging. 11: 437-49. PMID 2381503 DOI: 10.1016/0197-4580(90)90011-N |
0.418 |
|
| 1990 |
Hamon M, Gozlan H, el Mestikawy S, Emerit MB, Bolaños F, Schechter L. The central 5-HT1A receptors: pharmacological, biochemical, functional, and regulatory properties. Annals of the New York Academy of Sciences. 600: 114-29; discussion 1. PMID 2252305 DOI: 10.1111/J.1749-6632.1990.Tb16877.X |
0.367 |
|
| 1990 |
el Mestikawy S, Riad M, Laporte AM, Vergé D, Daval G, Gozlan H, Hamon M. Production of specific anti-rat 5-HT1A receptor antibodies in rabbits injected with a synthetic peptide. Neuroscience Letters. 118: 189-92. PMID 2148816 DOI: 10.1016/0304-3940(90)90623-H |
0.39 |
|
| 1990 |
Emerit MB, el Mestikawy S, Gozlan H, Rouot B, Hamon M. Physical evidence of the coupling of solubilized 5-HT1A binding sites with G regulatory proteins. Biochemical Pharmacology. 39: 7-18. PMID 2136995 DOI: 10.1016/0006-2952(90)90642-X |
0.375 |
|
| 1990 |
Sotelo C, Cholley B, El Mestikawy S, Gozlan H, Hamon M. Direct immunohistochemical evidence of the existence of 5-HT(1A) autoreceptors on serotoninergic neurons in the midbrain raphe nuclei European Journal of Neuroscience. 2: 1144-1154. DOI: 10.1111/j.1460-9568.1990.tb00026.x |
0.377 |
|
| 1988 |
el Mestikawy S, Cognard C, Gozlan H, Hamon M. Pharmacological and biochemical characterization of rat hippocampal 5-hydroxytryptamine1A receptors solubilized by 3-[3-(cholamidopropyl)dimethylammonio]-1-propane sulfonate (CHAPS). Journal of Neurochemistry. 51: 1031-40. PMID 2971097 DOI: 10.1111/J.1471-4159.1988.Tb03064.X |
0.383 |
|
| 1987 |
Emerit MB, el Mestikawy S, Gozlan H, Cossery JM, Besselievre R, Marquet A, Hamon M. Identification of the 5-HT1A receptor binding subunit in rat brain membranes using the photoaffinity probe [3H]8-methoxy-2-[N-n-propyl, N-3-(2-nitro-4-azidophenyl)aminopropyl]aminotetralin. Journal of Neurochemistry. 49: 373-80. PMID 3598578 DOI: 10.1111/J.1471-4159.1987.Tb02875.X |
0.403 |
|
| 1986 |
Soubrie P, Martin P, el Mestikawy S, Thiebot MH, Simon P, Hamon M. The lesion of serotonergic neurons does not prevent antidepressant-induced reversal of escape failures produced by inescapable shocks in rats. Pharmacology, Biochemistry, and Behavior. 25: 1-6. PMID 3749215 DOI: 10.1016/0091-3057(86)90220-0 |
0.414 |
|
| 1986 |
Hall MD, Gozlan H, Emerit MB, el Mestikawy S, Pichat L, Hamon M. Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents. Neurochemical Research. 11: 891-912. PMID 3016581 DOI: 10.1007/Bf00965212 |
0.383 |
|
| 1986 |
el Mestikawy S, Hamon M. Is dopamine-induced inhibition of adenylate cyclase involved in the autoreceptor-mediated negative control of tyrosine hydroxylase in striatal dopaminergic terminals? Journal of Neurochemistry. 47: 1425-33. PMID 2876053 DOI: 10.1111/J.1471-4159.1986.Tb00775.X |
0.417 |
|
| 1986 |
el Mestikawy S, Glowinski J, Hamon M. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals. Journal of Neurochemistry. 46: 12-22. PMID 2866232 DOI: 10.1111/J.1471-4159.1986.Tb12919.X |
0.417 |
|
| 1985 |
el Mestikawy S, Gozlan H, Glowinski J, Hamon M. Characteristics of tyrosine hydroxylase activation by K+-induced depolarization and/or forskolin in rat striatal slices. Journal of Neurochemistry. 45: 173-84. PMID 2860207 DOI: 10.1111/J.1471-4159.1985.Tb05490.X |
0.386 |
|
| 1983 |
Gozlan H, El Mestikawy S, Pichat L, Glowinski J, Hamon M. Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature. 305: 140-2. PMID 6225026 DOI: 10.1038/305140a0 |
0.388 |
|
| 1983 |
El Mestikawy S, Glowinski J, Hamon M. Tyrosine hydroxylase activation in depolarized dopaminergic terminals--involvement of Ca2+-dependent phosphorylation. Nature. 302: 830-2. PMID 6133218 DOI: 10.1038/302830a0 |
0.392 |
|
| 1982 |
El Mestikawy S, Goetz C, Pasquier A, Glowinski J, Hamon M. Long-term local and distal increases in tryptophan hydroxylase activity following intracerebral kainic acid injections in the rat. Brain Research. 244: 319-29. PMID 7116178 DOI: 10.1016/0006-8993(82)90091-9 |
0.54 |
|
| Show low-probability matches. |